Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 7/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 8/20 | 0.34 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.34 |
| ▸ | NMT1 | P30419 | 1/20 | 0.34 |
| ▸ | ACLY | P53396 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5402335 | 0.94 | PTGDR2 (0.38) | HTR6PTGDR2PTGDRALDH1A1MAPT | |
| SCHEMBL5424101 | 0.87 | PKM (0.35) | HTR6PTGDR2PTGDRACLY | |
| SCHEMBL5420513 | 0.87 | PTGDR2 (0.44) | HTR6PTGDR2PTGDRCYP3A4CYP2D6 | |
| SCHEMBL5328556 | 0.85 | HTR6 (0.50) | HTR6PTGDR2PTGDR | |
| SCHEMBL5334910 | 0.82 | HTR6 (0.41) | HTR6PTGDR2PTGDRNMT1ALDH1A1 | |
| SCHEMBL5330799 | 0.82 | HTR6 (0.45) | HTR6PTGDR2ACLYMAPT | |
| SCHEMBL5331513 | 0.82 | ACLY (0.40) | HTR6PTGDR2PTGDRACLY | |
| SCHEMBL5407866 | 0.81 | PTGDR2 (0.52) | HTR6PTGDR2PTGDR | |
| SCHEMBL5325372 | 0.80 | HTR6 (0.48) | HTR6PTGDR2PTGDRACLY | |
| SCHEMBL5329812 | 0.80 | HTR6 (0.43) | HTR6PTGDR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007020653-A1 | THIOETHER DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2007-02-22 | — | — | WO | disclosed |